Neuro-Oncology Reviews

Volume 25 Number 22
30 November 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 22, 30 November

Begagić E, Pugonja R, Bečulić H, Čeliković A, Tandir Lihić L, Kadić Vukas S, Čejvan L, Skomorac R, Selimović E, Jaganjac B, Juković-Bihorac F, Jusić A, Pojskić M.
Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings.
Brain Sci. 2023 Nov 17;13(11):1602. doi: 10.3390/brainsci13111602. PMID: 38002561. Review.

Kumar N, Khurana B, Arora D.
Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions.
Pharm Dev Technol. 2023 Nov 17:1-16. doi: 10.1080/10837450.2023.2285506. PMID: 37975846. Review˰

Trevisi G, Mangiola A.
Current Knowledge about the Peritumoral Microenvironment in Glioblastoma.
Cancers (Basel). 2023 Nov 17;15(22):5460. doi: 10.3390/cancers15225460. PMID: 38001721. Review.

Brosque A, Friedmann-Morvinski D.
Drivers of heterogeneity in the glioblastoma immune microenvironment.
Curr Opin Cell Biol. 2023 Nov 18;85:102279. doi: 10.1016/ PMID: 37984008. Review˰

Fu AY, Kavia J, Yadava Y, Srinivasan A, Hargwood P, Mazzola CA, Ammar A.
Biopsy of diffuse midline glioma is safe and impacts targeted therapy: a systematic review and meta-analysis.
Childs Nerv Syst. 2023 Nov 18. doi: 10.1007/s00381-023-06208-4. PMID: 37980290. Review, Meta-analysis˰

Huang WZ, Chen HC, Chang TK, You WC, Jan YJ, Chou YC.
Extracranial metastasis of pediatric glioblastoma: case report and literature review.
Childs Nerv Syst. 2023 Nov 20. doi: 10.1007/s00381-023-06229-z. PMID: 37982875. Case report, Review˰

Picca A, Bruno F, Nichelli L, Sanson M, Rudà R.
Advances in molecular and imaging biomarkers in lower-grade gliomas.
Expert Rev Neurother. 2023 Nov 20:1-15. doi: 10.1080/14737175.2023.2285472. PMID: 37982735. Review˰

Habibi MA, Aghaei F, Tajabadi Z, Mirjani MS, Minaee P, Eazi S.
The performance of Machine Learning for prediction of H3K27M Mutation in Midline Gliomas; A Systematic Review and Meta-Analysis.
World Neurosurg. 2023 Nov 22:S1878-8750(23)01624-8. doi: 10.1016/j.wneu.2023.11.061. PMID: 37995996. Review, Meta-analysis˰

Hoebel KV, Bridge CP, Ahmed S, Akintola O, Chung C, Huang RY, Johnson JM, Kim A, Ly KI, Chang K, Patel J, Pinho M, Batchelor TT, Rosen BR, Gerstner ER, Kalpathy-Cramer J.
Expert-centered Evaluation of Deep Learning Algorithms for Brain Tumor Segmentation.
Radiol Artif Intell. 2023 Nov 22;6(1):e220231. doi: 10.1148/ryai.220231. PMID: 38197800. Review. ˍ

Lan YL, Zou S, Wang W, Chen Q, Zhu Y.
Progress in cancer neuroscience.
MedComm (2020). 2023 Nov 22;4(6):e431. doi: 10.1002/mco2.431. PMID: 38020711. Review.


Chen E, Ling AL, Reardon DA, Chiocca EA.
Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?
Neuro Oncol. 2023 Nov 23:noad211. doi: 10.1093/neuonc/noad211. PMID: 37995317. Review.

Malik JR, Podany AT, Khan P, Shaffer CL, Siddiqui JA, Baranowska-Kortylewicz J, Le J, Fletcher CV, Ether SA, Avedissian SN.
Chemotherapy in pediatric brain tumor and the challenge of the blood-brain barrier.
Cancer Med. 2023 Nov 23. doi: 10.1002/cam4.6647∟. PMID: 37997517∟. Review.

Picca A, Sansone G, Santonocito OS, Mazzanti CM, Sanson M, Di Stefano AL.
Diffuse Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks, and Therapeutic Perspectives.
Cancers (Basel). 2023 Nov 23;15(23):5555. doi: 10.3390/cancers15235555. PMID: 38067258. Review.

Bo Y, Mu L, Yang Z, Li W, Jin M.
Research progress on ferroptosis in gliomas (Review).
Oncol Lett. 2023 Nov 27;27(1):36. doi: 10.3892/ol.2023.14169. PMID: 38108075. Review.

Andrews CE, Zilberberg J, Perez-Olle R, Exley MA, Andrews DW.
Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy.
J Neurooncol. 2023 Nov 29. doi: 10.1007/s11060-023-04491-4. PMID: 38017340. Review
. ˍ

Riviere-Cazaux C, Carlstrom LP, Neth BJ, Olson IE, Rajani K, Rahman M, Ikram S, Mansour MA, Mukherjee B, Warrington AE, Short SC, von Zglinicki T, Brown DA, Burma S, Tchkonia T, Schafer MJ, Baker DJ, Kizilbash SH, Kirkland JL, Burns TC.
An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence.
NPJ Precis Oncol. 2023 Nov 29;7(1):126. doi: 10.1038/s41698-023-00476-8. PMID: 38030881. Review. ˍ

Kaina B.
Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic Implications.
J Clin Med. 2023 Nov 30;12(23):7442. doi: 10.3390/jcm12237442. PMID: 38068493. Review. ˍ

Martinez PJ, Green AL, Borden MA.
Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening.
J Control Release. 2023 Nov 30;365:412-421. doi: 10.1016/j.jconrel.2023.11.037. PMID: 38000663. Review˰